Advanced therapies are paving the way for the next generation of medicine. Listen as Fran Gregory, PharmD, MBA, VP of emerging therapies at Cardinal Health discusses the current cell and gene therapy landscape, including insights into the product pipeline, cost structures, the current regulatory environment and reimbursement. #cellandgenetherapy
In our recent podcast, we spoke with Fran Gregory, PharmD, MBA, Vice President of Emerging Therapies at Cardinal Health about the cell and gene therapy landscape, innovative solutions to reduce cost, the regulatory environment, and reimbursement. https://lnkd.in/gTVKJQpe
